StonvexLoading…
StonvexStonvexStonvexCore line items from ICU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $495.00K | $1.23M | $814.00K | $631.00K |
Operating Income | $-3.60M | $-12.18M | $-9.16M | $-5.58M |
Net Income | $-3.52M | $-12.15M | $-9.25M | $-2.00M |
EPS (Diluted) | $-0.90 | $-5.86 | $-0.60 | $-0.58 |
Total Assets | $11.26M | $14.16M | $15.53M | $8.38M |
Total Liabilities | $3.95M | $3.74M | $4.07M | $5.04M |
Cash & Equivalents | $9.35M | $11.98M | $13.76M | $6.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.99M | 3.84M | 34.10M | 17.34M |